Moyamoya Disease Treatment Market Analysis with Trends, Analysis Share, Industry Size, Opportunities, Analysis and Forecast 

Market Highlights

Moyamoya disease (MMD) is a rare, cerebrovascular disorder which occurs due to blocked arteries at the base of the brain i.e. the basal ganglia. The MMD primarily affects children, but it can also occur in adults. A number of factor such as growing public awareness, technological advancements, rising prevalence of neurological disorders, increasing awareness, improving regulatory framework, increasing government assistance, increasing adoption rate, and rising funding and reimbursement policies are propelling the growth of the global moyamoya disease market. However, challenges in research and development, side-effects of treatment, the high cost of treatment, the presence of misbranded and spurious drugs and poor healthcare system in low and middle-income countries may hamper the growth of the market over the review period. It is estimated that the moyamoya disease market is expected to grow at a CAGR of 7.0% during the forecast period 2017-2023.

 Request Sample Copy

https://www.marketresearchfuture.com/sample_request/5275

 Regional Analysis

The Americas dominate the moyamoya disease market owing to the rising awareness among people, and high healthcare expenditure. According to the Centers for Disease Control and Prevention in 2015, the total health expenditure in the United States was reported to be USD 3.2 trillion and hospital care accounted for a share of 32.3%. 

Europe holds the second position in the moyamoya disease market. It is expected that the support provided by the government bodies for research & development and improvement in the reimbursement policies in the healthcare is likely to drive the market of Europe region.

 The Asia Pacific is the fastest growing moyamoya disease market owing to a huge patient pool and developing healthcare technology. Healthcare expenditure is also improving in various Asia Pacific countries. According to the Australian Institute of Health and Welfare in the years 2015-2016, the total health expenditure was USD 170.4 billion, which is 3.6% higher than the expenditure of 2014-2015.

 The Middle East & Africa holds the lowest market due to lack of technical knowledge and poor medical facilities.

 Segmentation

The global Moyamoya Disease Treatment Market Analysis is segmented on the basis of diagnosis, treatment, and distribution channels.

 On the basis of the diagnosis, the market is classified as a cerebral angiogram, magnetic resonance imaging (MRI), magnetic resonance angiogram (MRA), computed tomography (CT) scans, transcranial Doppler ultrasound, positron emission tomography (PET) scan, and electroencephalography (EEG).

 On the basis of the treatment, the market is classified as surgical treatment and non-surgical treatment. The surgical treatment is further classified as pial synangiosis, indirect procedures, and direct arterial bypass. The sub-segment of indirect procedures includes EDAS (encephaloduroarteriosynangiosis), EMS (encephalomyosynangiosis), Omental transposition/transfer, and dural inversion. The non-surgical treatment is further classified as anticoagulation and antiplatelet therapy, and others. The sub-segment of anticoagulation and antiplatelet therapy include heparin, warfarin, aspirin, and others.

 On the basis of the distribution channel, the market is segmented into hospitals, clinics, diagnostic centers, drug stores, pharmacies, and others.

 Key Players

Some of key the players in the global moyamoya disease market are Abbott Laboratories, Medtronic plc, Boston Scientific Corporation, Cordis Corporation, Koninklijke Philips N.V., GE Healthcare, Siemens, Stryker, Genentech Inc., Merck & Co. Inc., UCB Pharma Ltd., Sanofi, Valeant Pharmaceuticals International, Inc., Pfizer, Inc., Johnson & Johnson, Eisai Co., Ltd, Novartis AG, GlaxoSmithKline plc, Sunovion Pharmaceuticals, Inc., Cephalon, Inc., and others. 

Browse Full Report @

https://www.marketresearchfuture.com/reports/moyamoya-disease-market-5275

 NOTE: Our team of researchers are studying Covid19 and its impact on various industry verticals and wherever required we will be considering covid19 footprints for a better analysis of markets and industries. Cordially get in touch for more details.

 About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

 Contact:

Akash Anand

Market Research Future

+1 646 845 9312

Email: sales@marketresearchfuture.com

Comments

Post a Comment

Popular posts from this blog

Immunotherapy Drugs market Size Witness A Considerable CAGR Growth Through The Forecast Period

  Recently added new market study, titled “Immunotherapy Drugs market Research Report - Forecast to 2023” by Market Research Future (MRFR) Therapies like chemotherapy and other radiotherapy is not effective in melanoma cancer. Immunotherapies show a better result for the treatment of melanoma cancer. Immunotherapies are used for limited number of cancer treatment mostly hematological, but they show better results where other therapy is not effective. Increasing cancer population, increasing healthcare expenditure with rising government support for research & development are the major driving factor for the market. Majority of manufacturers are actively working in research & development of immunotherapy drugs because of huge necessities like better treatment.   Also Read: https://www.medgadget.com/2020/06/immunotherapy-drugs-market-size-projection-future-growth-share-value-covid-19-impact-analysis-and-sales-insights-by-2023.html   Some manufactures are tryi...
Read more

Concussions Market By Global Analysis, Research, Review, Applications and Forecast

  Concussions Market – Overview Concussions are among the more frequently caused brain injuries which do not require extensive care or medication. Reports that gauge the healthcare industry have been made available by Market Research Future which creates reports on several industry verticals that review the market growth and prospects. The market is on track to touch a CAGR of 3.22% and accumulate revenue worth USD 1,060.4 million at the end of the forecast period. The concussions market has grown in the past few years due to the rising population bases globally. Moreover, individuals are also increasingly engaging in adventure sports and thrill-seeking activities which have drastically increased the incidence of concussions. Also, improvement in concussion management procedures is expected to further incentivize the market growth in the forthcoming forecast period. Request Sample Copy: https://www.marketresearchfuture.com/sample_request/5724 Concussions Market Segmental Analy...
Read more

Gold Nanoparticles Market in Americas Including Top Key Players, Trends And Emerging Growth Factors

Gold nanoparticles (AuNPs) have applications in drug delivery, sensory probes, therapeutic agents, and photovoltaics due to its optoelectronic properties. They are used in conjunction with ionizing and non-ionizing radiation for eliminating cancer tumors. The Americas gold nanoparticles market report by Market Research Future (MRFR) focuses on the types of nanoparticles as well as their applications in thorough detail. Request Sample Copy: https://www.marketresearchfuture.com/sample_request/1129 Market Outlook The Americas gold nanoparticles market size can expand at 16.5% CAGR from 2017 to 2023 (forecast period). The application of these particles for sensing selective biomolecules in the body can drive the market demand. Increasing adoption of nanotechnology in the healthcare sector coupled with rising prevalence of cancer and other chronic diseases can fuel the market demand over the forecast period. According to the Center for Disease Control & Prevention (CDC), c...
Read more